祛湿凉血方治疗慢性湿疹的疗效观察

Qushi Liangxue Decoction in treatment of chronic eczema

  • 摘要: 目的 观察祛湿凉血方治疗慢性湿疹的临床疗效。 方法 将解放军总医院海南分院120例确诊为慢性湿疹的患者随机分为治疗组与对照组各60例,其中治疗组脱落2例,对照组脱落1例。治疗组给予口服祛湿凉血方(主要成分为龙胆草、炒栀子、生地黄、生薏仁等)1剂/d,2次/d;对照组给予复方氟米松软膏外涂2次/d,两组治疗疗程均为4周。实验结束后进行治疗前后皮损面积及严重度指数(eczema area and severity index,EASI)评分、瘙痒程度评分(VAS)并比较总有效率、复发率。 结果 治疗4周后中药组EASI评分及不良反应发生率均低于对照组EASI:1.40(1.98) vs 1.60(2.00);不良反应:3.45% vs 10.17%,但差异无统计学意义(P均> 0.05)。治疗组总有效率(87.9%)高于对照组(79.6%),但差异无统计学意义(P> 0.05)。治疗组VAS评分及治疗后3个月复发率显著低于对照组VAS:2.00(4.00) vs 5.00(5.00);复发率:10.3% vs 25.4%,差异有统计学意义(P均< 0.05)。 结论 祛湿凉血方能有效改善慢性湿疹EASI、VAS评分,具有较好临床疗效,且复发率较低、安全性较好。

     

    Abstract: Objective To observe the clinical effect of Qushi Liangxue Decoction in treatment of chronic eczema. Methods A total of 120 patients with chronic eczema were randomly divided into two groups: treatment group (n=60) and western medicine control group (n=60). Two cases in treatment group and one case in control group dropped out. Patients in treatment group were treated with Qushi Liangxue Decoction for one dose twice a day and the control group was treated with compound ointment twice a day. Both two groups were treated for 4 weeks. EASI, VAS score, total effective rate and recurrence rate were compared before and after treatment. Results After 4 weeks of treatment, the EASI and side effect rate in the treatment group were lower than those in the control group with no significant difference 1.40 (1.98) vs 1.60 (2.00), 3.45% vs 10.17%; P> 0.05, respectively. The total effective rate in the treatment group was higher than that in the control group with no significant difference (87.9% vs 79.6%, P> 0.05). The VAS score and the recurrence rate in the treatment group were significantly lower than those in the control group with significant difference2.00 (4.00) vs 5.00 (5.00), 10.3% vs 25.4%; P< 0.05, respectively. Conclusion Qushi Liangxue Decoction is effective and safe in treating patients with chronic eczema, with less recurrence.

     

/

返回文章
返回